Hers vs Mochi Health: Coverage, Program Model, and Medication

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

The sharpest difference between two GLP-1 telehealth brands is often not the medicine at all, but how they treat your insurance. This PlexusDx Education Hub review compares Hers and Mochi Health with coverage front of mind, then examines a biological variable that no plan and no program accounts for. Browse all Peptides & GLP-1 education.

A note on independence: PlexusDx has no commercial tie to Hers, Mochi Health, or their owners. This review carries no affiliate links, no sponsorship, and no referral compensation.

Hers and Mochi Health both live in the online weight-management category, but they approach payment from opposite ends. Below, we look at how each program is organized, what "insurance support" actually buys you, how cost is assembled, and one inherited factor that sits outside every billing conversation. Market details are current as of April 2026.

Hers at a glance

Hers, part of Hims & Hers Health, runs a subscription-telehealth program. Patients complete a virtual intake, a licensed clinician evaluates eligibility, and an appropriate prescription follows, either an FDA-approved brand GLP-1 or a compounded semaglutide or tirzepatide from a licensed compounding pharmacy. Program terms are published at Hers's official website.

Mochi Health at a glance

Mochi Health pairs telehealth with insurance-navigation support, positioning coverage assistance as part of the service. Its medication options, membership structure, and fees change over time; the current picture lives on Mochi Health's official website at the moment you read it.

What "insurance support" really means here

Coverage for GLP-1 therapy is uneven. Many cash-pay compounded telehealth programs sit entirely outside insurance, while a program that offers benefits navigation may help you pursue coverage of a branded, FDA-approved product when your plan allows it. Neither approach guarantees an approval. Support means help with paperwork and eligibility checks, not a promise that a payer will say yes. Read the fine print on what is billed to you regardless of the coverage outcome.

The medicine is the same class either way

Whether you pay cash or route a claim, the underlying compounds behave identically. GLP-1 receptor agonists, including semaglutide, liraglutide, and dulaglutide, and the dual GIP/GLP-1 agonist tirzepatide, influence appetite, satiety, and gastric emptying. Coverage and branding change what you pay and how you obtain the drug; they do not change its mechanism. What differs between Hers and Mochi is the model and the payment path, not the pharmacology.

How the total comes together

Across the category as of April 2026, out-of-pocket monthly totals commonly range from about $200 to $700 or more when coverage does not apply, driven by the compound, the plan length, and dispensing fees. If a plan covers a branded product, your share may differ substantially. Because these figures move and depend heavily on your benefits, confirm current pricing and coverage terms directly with each brand before deciding.

What the trials established

The compounds themselves are well studied. STEP examined semaglutide for weight management (New England Journal of Medicine, 2021); SURMOUNT examined tirzepatide for weight management (NEJM, 2022); and SURMOUNT-OSA looked at tirzepatide in obstructive sleep apnea (NEJM, 2024). These programs used different doses, endpoints, and populations, and no trial average predicts an individual outcome.

The inherited factor no plan covers

Insurance can shape what you pay, but it says nothing about the biology a GLP-1 acts on. Variation in MC4R, a melanocortin receptor central to satiety, together with FTO, GLP1R (the receptor these compounds target), and TCF7L2 (linked to glucose regulation), outlines your baseline metabolic terrain. These pathway-level markers do not predict how a specific drug will perform, but they describe the ground a clinician is prescribing onto, which no benefits check captures.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Before any protocol begins, the Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights spanning FTO, MC4R, and TCF7L2, turning a prescription into an informed conversation. Test before you invest.

Not affiliated: PlexusDx has no relationship with Hers or Mochi Health and reviewed both independently.

Related reading on PlexusDx: GLP 1 Receptor Agonist, GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1.

Disclaimer: This article is educational. PlexusDx is not affiliated with Hers or Mochi Health and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways and does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Start with your biology: take the Precision Peptide Genetic Test, or explore the Weight Management Protocols.

Frequently Asked Questions

Does Mochi Health guarantee my insurance will cover a GLP-1?

No program can guarantee coverage. Mochi Health positions insurance navigation as part of its service, which can mean help checking eligibility and filing for a branded product. Whether a payer approves depends on your specific plan and clinical criteria, so confirm what is billed to you if coverage is denied.

Is Hers a cash-pay or insurance program?

Hers largely operates as a subscription-telehealth service, and compounded GLP-1 options in this model are typically cash-pay rather than billed to insurance. Program and payment details are published on the brand's own site, so verify current terms there before assuming any coverage applies to your situation.

Can the Precision Peptide Genetic Test help with coverage decisions?

No. The test is not a coverage tool and does not predict drug response. It maps pathway-level variants such as FTO and MC4R, and TCF7L2 that describe your baseline metabolic biology, giving you and your provider context that applies regardless of how your care is ultimately paid for.

How is PlexusDx different from a coverage-focused program?

PlexusDx focuses on the biology rather than the billing. It provides semaglutide and tirzepatide through its Weight Management Protocols and adds upstream genetic context via the Precision Peptide Genetic Test, mapping FTO, MC4R, a layer neither Hers nor Mochi Health offers.

More in the Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.